Gene · 10551
Papers1,931
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,931
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anterior gradient 2 is overexpressed in extramammary Paget's disease and involved in cell survival. | J Dermatol Sci | 2026 | 42816243 | PubTator, text mining | PubMed |
| How Does Inter-Epitope Spacer Variation Within Artificial Immunogens Based on T-Cell Epitopes of Tick-Borne Encephalitis Virus Affect Immunogenicity? | Vaccines (Basel) | 2026 | 42797590 | PubTator, text mining | PubMed |
| Complementary intra- and extracellular AGR2 activities support epithelial ovarian cancer cell aggressiveness. | Oncogene | 2026 | 42575981 | PubTator, text mining | PubMed |
| Context-dependent promotion of epithelial-mesenchymal transition by IL-13Rα2/STAT6 signaling in colorectal cancer. | Mol Cell Biochem | 2026 | 42573974 | PubTator, text mining | PubMed |
| Integrative Analysis Identified an Eight-Gene Risk Signature Linked to CDK7 and Explored Its Association with HCC Progression via RelA Phosphorylation. | Oncol Res | 2026 | 42500561 | PubTator, text mining | PubMed |
| A rare cause of congenital diarrhea: a homozygous AGR2 frameshift variant in an infant. | Turk J Pediatr | 2026 | 42497436 | PubTator, text mining | PubMed |
| Genetic regulatory axis between AGR2 and ESR1 promotes breast cancer progression. | PLoS One | 2026 | 42384634 | PubTator, text mining | PubMed |
| Cross-species systems analysis distinguishes inflammatory remodeling from primary mucus secretory failure in inflammatory bowel disease. | Front Immunol | 2026 | 42344920 | PubTator, text mining | PubMed |
| Inhibition of AGR2 triggers secretion of GRP78 and sensitizes gastroesophageal junction adenocarcinoma cells to ER stress. | Biochem Biophys Res Commun | 2026 | 42330887 | PubTator, text mining | PubMed |
| Erratum: AGR2 promotes the proliferation, migration and regulates epithelial-mesenchymal transition in salivary adenoid cystic carcinoma. | Am J Transl Res | 2026 | 42325778 | PubTator, text mining | PubMed |
| AGR2-high cells drive a FOXM1-mediated pro-malignancy program in non-functional pancreatic neuroendocrine tumors (NF-PanNETs) and informatively predict patient outcomes. | Sci Bull (Beijing) | 2026 | 42321044 | PubTator, text mining | PubMed |
| Development of a rapid and sensitive EnLIGHT OMEGA assay for extracellular AGR2 detection in biological fluids. | SLAS Discov | 2026 | 42269775 | PubTator, text mining | PubMed |
| Tumor-Associated Neutrophils Secrete AGR2 to Promote Colorectal Cancer Progression by Stabilizing ALYREF to Boost Snail m5C Modification. | FASEB J | 2026 | 42241033 | PubTator, text mining | PubMed |
| Antitumor activity of silver (Ag) complexes in colorectal cancer cells by oxidative stress and apoptosis induction. | Ther Deliv | 2026 | 42148666 | PubTator, text mining | PubMed |
| Non-invasive host transcriptome and HPV oncogene expression map the molecular landscape of HPV-driven cervical lesions. | PLoS One | 2026 | 41855211 | PubTator, text mining | PubMed |
| AGR2 promotes tumor progression by regulating macrophage polarization via the CD98hc-xCT/p-ERK pathway. | Front Immunol | 2026 | 41836390 | PubTator, text mining | PubMed |
| S100A14 Facilitates Pancreatic Cancer Progression via S100A16-Mediated p53 Suppression. | Oncol Res | 2026 | 41799516 | PubTator, text mining | PubMed |
| Restoring Ag1, an ancient regeneration gene lost in amniotes, accelerates skin healing in mice. | Front Cell Dev Biol | 2026 | 41799438 | PubTator, text mining | PubMed |
A label-free microLC-SWATH-MS methodology with immunoaffinity depletion of highly abundant serum proteins for quantitative proteomic comparison of fresh-frozen human normal breast tissue and tumor clinical specimens. | Front Mol Biosci | 2026 | 41797989 | PubTator, text mining | PubMed |
| lncRNA AL445238.2‑USP4 axis regulates cell survival and stemness in colon cancer. | Int J Oncol | 2026 | 41789601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10551/papers